
Evolution of the Utilization of the Alfa 5% Fund for Orphan Drugs and Rare Diseases
The poster addresses the evolution of the utilization of the AIFA 5% Fund, established in 2003 for the acquisition of orphan drugs and the treatment
The poster addresses the evolution of the utilization of the AIFA 5% Fund, established in 2003 for the acquisition of orphan drugs and the treatment
PHARMA VALUE Srl unipersonale
C.F./P.IVA 17063271005
R.E.A. CCIAA di Roma n.1693269
Sede Legale e Operativa: via Sistina, 121 – 00187 – Roma
PEC: pharmavalue@legalmail.it
Contatti: info@pharmavalue.it | 0647818478 – 0647818479
Disegno e sviluppo G Tech Group & Gianluca Gentile